Topic: diagnostic imaging
The health of the placenta is vitally important during a pregnancy, but assessing it can be a challenge.
Lantheus, makers of diagnostic imaging hardware and nuclear medicine agents, has moved to acquire cancer drugmaker Progenics Pharmaceuticals.
Paragon Biosciences built a new portfolio company around its acquisition of the first FDA-cleared AI system for diagnosing breast cancer.
Roche and GE have launched the Navify Tumor Board 2.0, which incorporates medical image viewing with in vitro lab tests and other patient data.
GE has submitted a confidential IPO filing to spin out its healthcare business into a publicly traded company, according to reports.
Butterfly Network has raised $250 million that will bankroll the manufacturing and shipping of its hand-held ultrasound devices.
The FDA approved Endomag’s nonradioactive, magnetic, liquid tracer for mapping lymph nodes in breast cancer patients undergoing mastectomy.
MedyMatch is working on artificial intelligence- and machine learning-based solutions to improve the quality and delivery of healthcare, with the ultimate goal of improving outcomes and driving down costs.
Butterfly Network’s ultrasound-on-a-chip technology snagged the FDA nod for 13 applications.
2016 saw GE Healthcare return to growth after a 3.6% decline the year before, making up 15% of GE’s 2016 revenues. After investing $300 million into a new business dedicated to emerging markets, GE experienced great sales growth in those regions.